Childhood malignancies in French Polynesia during the 1985-1995 period

Tropical Medicine & International Health : TM & IH
Cécile Challeton-De VathaireFrançois Laudon

Abstract

We report an estimation of the incidence of childhood cancer among natives of French Polynesia (FP) during the 1985-1995 period. Our data were acquired from the Cancer Registry of FP and through an extensive investigation of other potential sources of information. The mean population of children between 1985 and 1995 was estimated to be 63 401 inhabitants, 32 487 of whom were boys and 30 914 girls, born and residing in FP. During the 1985-1995 period, 87 incident cases of childhood cancer were recorded among inhabitants born in FP or of an unknown place of birth (n = 2). Childhood cancer incidence had attained 125 cases/million child years and was very similar among girls (126 x 10(-6)) and boys (123 x 10(-6)), this incidence being slightly lower than among other populations of similar ethnic origin: Standardized Incidence Ratio (SIR) = 0.8 (95% CI: 0.7-1.0) when compared with New Zealand Maoris and SIR = 0.8 (95% CI: 0.6-1.0) when compared with natives from Hawaii. For both sexes considered together, the most frequent cancer type was leukaemia, followed by central nervous system (CNS) malignancies, neuroblastoma, and non-Hodgkin's lymphoma (NHL). Only one case of gonadal and germ cell tumours and one case of carcinoma were rep...Continue Reading

References

Jan 15, 1992·American Journal of Epidemiology·E A HollyJ J Kristiansen
Feb 14, 1991·The New England Journal of Medicine·W M Crist, L E Kun
Jul 15, 1991·Cancer·D RidgwayD M Becroft
Dec 1, 1990·British Journal of Cancer·C A Stiller, D M Parkin
Jul 1, 1989·British Journal of Cancer·M T GoodmanL N Kolonel
Oct 15, 1988·International Journal of Cancer. Journal International Du Cancer·D M ParkinC A Bieber
Aug 1, 1986·American Journal of Clinical Oncology·P ZamoraJ M González
May 1, 1996·British Journal of Cancer·J D DockertyM G Cockburn
Dec 11, 1996·International Journal of Cancer. Journal International Du Cancer·E Kramárová, C A Stiller
Mar 13, 1999·International Journal of Cancer. Journal International Du Cancer·D M ParkinJ Ferlay
Oct 24, 2000·Tropical Medicine & International Health : TM & IH·B Le VuF Laudon

❮ Previous
Next ❯

Citations

Feb 1, 2014·The Lancet Oncology·Patricia C ValeryFreddie Bray
Aug 10, 2019·The Lancet Oncology·Alec EkeromaDiana Sarfati

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

© 2021 Meta ULC. All rights reserved